End-of-day quote
Other stock markets
|
||
- | - |
04-29 | Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target | MT |
03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 471M 0 645M |
---|---|---|---|---|---|
Net income 2024 * | -66M - -90.31M | Net income 2025 * | -74M - -101M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M 0 448M | Net cash position 2025 * | 501M 0 686M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-9.49
x | P/E ratio 2025 * |
-10.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |